当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3759801
自主品牌
已选条件
-
T1024Roflumilast罗氟司特；BY 217；APTA 2217；B9302-107；BYK 20869
Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively
价 格：￥电议型 号：T1024产 地：中国大陆
-
T1024RoflumilastRoflumilast,APTA 2217,B9302-107
Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively
价 格：￥电议型 号：T1024产 地：美洲
-
T1024Roflumilast；罗氟司特B9302-107|||BYK 20869|||APTA 2217|||BY 217；罗氟司特|||B9302-107|||BYK 20869|||APTA 2217|
Roflumilast (APTA 2217) is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3´, 5´-adenosine monophosphate (cAMP) and cAMP-mediated signaling.
价 格：￥电议型 号：T1024产 地：中国大陆
